Genomics company Illumina (NASDAQ:ILMN) reported Q4 CY2024 results , but sales were flat year on year at $1.1 billion. On the ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...

If you work in cancer care, listen to Macmillan’s new podcast where you can hear from expert guests and find out about the ...

Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...

Postdoctoral scholar Daniela Soto has earned a prestigious fellowship from HHMI with eight years of funding to study the ...

Prof Moffat Nyirenda, Director of the MRC/UVRI and LSHTM Uganda Research Unit, emphasized the importance of collaboration in advancing genomics research in Africa. Thank you for reading Nation.Africa ...

EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

Low-cost passive index investing (in the S&P 500 or Nasdaq 100) has been key to impressive results in recent years. However, ...